Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;40:853-858
Published online before print November 11, 2002, doi: 10.1161/01.HYP.0000042096.17141.B1
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/6/853    most recent
01.HYP.0000042096.17141.B1v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Su, J.-Z.
Right arrow Articles by Miyazaki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Su, J.-Z.
Right arrow Articles by Miyazaki, H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ARGININE
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Cell biology/structural biology
Right arrow Smooth muscle proliferation and differentiation

(Hypertension. 2002;40:853.)
© 2002 American Heart Association, Inc.


Scientific Contributions

Effect of AT2 Receptor on Expression of AT1 and TGF-ß Receptors in VSMCs from SHR

Jin-Zi Su; Noboru Fukuda; Xue-Qing Jin; Yi-Mu Lai; Ryo Suzuki; Yoshiko Tahira; Hiroto Takagi; Yukihiro Ikeda; Katsuo Kanmatsuse; Hitoshi Miyazaki

From the Second Department of Internal Medicine, Nihon University School of Medicine (J.-Z.S., N.F., X.-Q.J., Y.-M.L., R.S., Y.T., H.T., Y.I., K.K.), Tokyo, Japan; and Gene Experiment Center, University of Tsukuba (H.M.), Ibaraki, Japan.

Correspondence to Noboru Fukuda, MD, PhD, Second Department of Internal Medicine, Nihon University School of Medicine, Ooyaguchi-kamimachi 30-1, Itabashi-ku, Tokyo 173-8610, Japan. E-mail nhukuda{at}med.nihon-u.ac.jp

We recently reported that overexpression of the angiotensin II type 2 (AT2) receptor downregulates the AT1a receptor through the bradykinin/NO pathway in a ligand-independent manner in vascular smooth muscle cells (VSMCs). In the present study, we investigated the effect of AT2 receptor overexpression on the expression of the AT1a receptor and transforming growth factor-ß (TGF-ß) receptor subtypes in VSMCs from spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY). Transfection of the AT2 receptor gene downregulated expression of the AT1a receptor in VSMCs from WKY, but did not affect expression of the AT1a receptor in VSMCs from SHR. Transfection of the AT2 receptor abolished DNA synthesis in response to angiotensin II in VSMCs from WKY; in VSMCs from SHR, basal DNA synthesis was suppressed, but DNA synthesis in response to Ang II was not altered. The NO substrate L-arginine augmented downregulation of the AT1a receptor in VSMCs from WKY, whereas it did not affect expression of the AT1a receptor in VSMCs from SHR. In response to AT2 receptor transfection, expression of TGF-ß type I receptor mRNA was suppressed significantly in VSMCs from WKY, whereas expression of TGF-ß type I receptor was not altered in VSMCs from SHR. These results suggest that the AT2 receptor downregulates AT1a and TGF-ß type I receptors in normal VSMCs, but not in SHR-derived VSMCs. The lack of downregulation of the AT1a receptor may contribute, in part, to the exaggerated growth of VSMCs from SHR.


Key Words: receptors, angiotensin II • muscle, smooth, vascular • rats, spontaneously hypertensive




This article has been cited by other articles:


Home page
HypertensionHome page
M. Gonzalez, L. Lobos, F. Castillo, L. Galleguillos, N. C. Lopez, and L. Michea
High-Salt Diet Inhibits Expression of Angiotensin Type 2 Receptor in Resistance Arteries
Hypertension, May 1, 2005; 45(5): 853 - 859.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. B. Anning, B. Coles, A. Bermudez-Fajardo, P. E.M. Martin, B. S. Levison, S. L. Hazen, C. D. Funk, H. Kuhn, and V. B. O'Donnell
Elevated Endothelial Nitric Oxide Bioactivity and Resistance to Angiotensin-Dependent Hypertension in 12/15-Lipoxygenase Knockout Mice
Am. J. Pathol., March 1, 2005; 166(3): 653 - 662.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Suarez, G. Diaz-Torga, A. Gonzalez-Iglesias, C. Cristina, and D. Becu-Villalobos
Upregulation of angiotensin II type 2 receptor expression in estrogen-induced pituitary hyperplasia
Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E786 - E794.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Palacios, E. T. Marusic, N. C. Lopez, M. Gonzalez, and L. Michea
Estradiol-induced expression of Na+-K+-ATPase catalytic isoforms in rat arteries: gender differences in activity mediated by nitric oxide donors
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1793 - H1800.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Suzuki, T. Yamamoto, N. Ikegaya, and A. Hishida
Dietary salt intake modulates progression of antithymocyte serum nephritis through alteration of glomerular angiotensin II receptor expression
Am J Physiol Renal Physiol, February 1, 2004; 286(2): F267 - F277.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. M. Carey and H. M. Siragy
Newly Recognized Components of the Renin-Angiotensin System: Potential Roles in Cardiovascular and Renal Regulation
Endocr. Rev., June 1, 2003; 24(3): 261 - 271.
[Abstract] [Full Text] [PDF]